Independence Blue Cross is tracking amputation risks among some diabetic members through a partnership with Somerville, Mass.-based Podimetrics.
The collaboration uses a cellular-connected SmartMat device that detects foot complications in some diabetic members up to five weeks before a clinician can, according to an Oct. 29 news release.
Members with a history of foot ulcers stand on a SmartMat for 20 seconds each day, and Podimetrics checks the temperature of their feet as a warning for potential complications.
Left untreated, complications can lead to patients needing amputations, which disproportionately affect minority communities, according to the release. The amputations can cost up to $100,000 and have a 62 percent five-year mortality rate.